Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-401310
Filing Date
2014-11-06
Accepted
2014-11-06 17:19:52
Documents
3
Period of Report
2014-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d815969d6k.htm 6-K 11038
2 EX-99.1 d815969dex991.htm EX-99.1 12329
3 GRAPHIC g815969imag001.jpg GRAPHIC 15794
  Complete submission text file 0001193125-14-401310.txt   46234
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 141201817
SIC: 2834 Pharmaceutical Preparations